Evidence map›Paper›PMID 27113199›Full record

Trial reportMayo Clinic proceedings2016

Reporting on the Strategies Needed to Implement Proven Interventions: An Example From a "Real-World" Cross-Setting Implementation Study.

Rachel Gold, Arwen E Bunce, Deborah J Cohen, Celine Hollombe, Christine A Nelson, Enola K Proctor, Jill A Pope, Jennifer E DeVoe

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Mayo Clinic proceedings, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02299791 (Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02299791 nacompletednot on this map

Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics

TypeinterventionalSponsorKaiser PermanenteRan2010 to 2014Enrolled4,856ConditionsDiabetes Mellitus, Cardiovascular DiseasesArmsALL
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. An introduction to implementation science in rehabilitation medicine.PM & R : the journal of injury, function, and rehabilitation · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rachel GoldKaiser Permanente Center for Health Research, Portland, Ore; OCHIN, Inc, Portland, Ore. Electronic address: rachel.gold@kpchr.org.
Arwen E BunceKaiser Permanente Center for Health Research, Portland, Ore.
Deborah J CohenDepartment of Family Medicine, Oregon Health & Science University, Portland, Ore.
Celine HollombeKaiser Permanente Center for Health Research, Portland, Ore.
Christine A NelsonOCHIN, Inc, Portland, Ore.
Enola K ProctorGeorge Warren Brown School of Social Work, Washington University, St Louis, Mo.
Jill A PopeKaiser Permanente Center for Health Research, Portland, Ore.
Jennifer E DeVoeDepartment of Family Medicine, Oregon Health & Science University, Portland, Ore; OCHIN, Inc, Portland, Ore.

Funding

Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Center for Diabetes Translation Research P30DK092950 · NIDDK · WASHINGTON UNIVERSITY · PI Ross C Brownson, Debra Haire-Joshu · 2011 to 2026
$11.7M
Worksite Policies and neighborhood Influences on Obesity and Cancer RiskU54CA155496 · NCI · WASHINGTON UNIVERSITY · PI COLDITZ, GRAHAM A. · 2011 to 2016
$9.0M
IMPLEMENTATION RESEARCH INSTITUTE FOR MENTAL HEALTH SERVICES IRI-MHSR25MH080916 · NIMH · WASHINGTON UNIVERSITY · PI Byron James Powell · 2009 to 2026
$3.7M
SPREAD-NET: PRactices Enabling Adapting and Disseminating in the safety NETR01HL120894 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI GOLD, RACHEL · 2014 to 2018
$3.6M
Dissemination of CVD risk factor treatment among diabetic patients in FQHCsR18HL095481 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI GOLD, RACHEL · 2010 to 2014
$3.1M
NCATS NIH HHS UL1 TR000448NCI NIH HHS U54 CA155496NCRR NIH HHS UL1 RR024992NHLBI NIH HHS R18 HL095481NIDDK NIH HHS P30 DK092950NIMH NIH HHS R25 MH080916
6 · The paper itself

Abstract

unlabelledThe objective of this study was to empirically demonstrate the use of a new framework for describing the strategies used to implement quality improvement interventions and provide an example that others may follow. Implementation strategies are the specific approaches, methods, structures, and resources used to introduce and encourage uptake of a given intervention's components. Such strategies have not been regularly reported in descriptions of interventions' effectiveness, or in assessments of how proven interventions are implemented in new settings. This lack of reporting may hinder efforts to successfully translate effective interventions into "real-world" practice. A recently published framework was designed to standardize reporting on implementation strategies in the implementation science literature. We applied this framework to describe the strategies used to implement a single intervention in its original commercial care setting, and when implemented in community health centers from September 2010 through May 2015. Per this framework, the target (clinic staff) and outcome (prescribing rates) remained the same across settings; the actor, action, temporality, and dose were adapted to fit local context. The framework proved helpful in articulating which of the implementation strategies were kept constant and which were tailored to fit diverse settings, and simplified our reporting of their effects. Researchers should consider consistently reporting this information, which could be crucial to the success or failure of implementing proven interventions effectively across diverse care settings.

trial registrationclinicaltrials.gov Identifier: NCT02299791.

Indexed as

Angiotensin-Converting Enzyme InhibitorsAspirinCardiotonic AgentsCardiovascular DiseasesDiabetes ComplicationsGuideline AdherenceHealth Maintenance OrganizationsHealth Plan ImplementationHumansHydroxymethylglutaryl-CoA Reductase InhibitorsPractice Guidelines as TopicQuality ImprovementAngiotensin-Converting Enzyme InhibitorsAspirinCardiotonic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID27113199
PMCPMC4975638

What OpenQuestion holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.